Recent Quotes (30 days)

You have no recent quotes
chg | %

Cml Healthcare Inc  

(Public, TSE:CLC)   Watch this stock  
Find more results for CLC
7.62
+0.01 (0.13%)
May 24 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 7.58 - 7.69
52 week 5.42 - 10.25
Open 7.60
Vol / Avg. 165,003.00/135,904.00
Mkt cap 684.60M
P/E 20.32
Div/yield 0.13/6.96
EPS 0.38
Shares 89.84M
Beta 0.06
Inst. own     -
Aug 5, 2013
Q2 2013 CML HealthCare Inc Earnings Release Add to calendar
May 8, 2013
CML HealthCare Inc Annual Shareholder Meeting
May 8, 2013
Q1 2013 CML HealthCare Inc Earnings Conference Call
May 8, 2013
Q1 2013 CML HealthCare Inc Earnings Release
Mar 7, 2013
Q4 2012 CML HealthCare Inc Earnings Conference Call
Mar 4, 2013
Q4 2012 CML HealthCare Inc Earnings Release
  

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 19.43% 11.22%
Operating margin 30.60% 19.09%
EBITD margin - 30.41%
Return on average assets 13.89% 10.05%
Return on average equity 324.32% 138.21%
Employees 1,400 -
Carbon Disclosure Rating - -

Address

Unit #1, 60 Courtneypark Dr. West
MISSISSAUGA, ON L5W 0B3
Canada
+1-905-5650043 (Phone)
+1-905-5652844 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

CML Healthcare Inc. (CML) is providing diagnostic medical care. The Company is a provider of community-based diagnostic testing services. In addition to its laboratory testing services involving hematology, biochemistry, cytology, microbiology, and histology, the Company is licensed to conduct a range of supporting diagnostic procedures, such as electro cardio grams, holter monitoring, and pulmonary function tests. In November 2011, it sold its medical imaging operations in the United States to RadNet, Inc. In December 2011, the Company announced the sale of two imaging centers in Maryland. Effective January 1, 2012, CML completed the purchase of 312244 B.C. Ltd. On October 1, 2012, it acquired Hemostasis Reference Laboratory Inc. In November 2012, the Company sold of its diagnostic imaging business in Alberta to Canada Diagnostic Centres (CDC). In May 2013, the Company acquired Rocky Mountain Analytical.

Officers and directors

Patrice E. Merrin Independent Chairman of the Board of Trustee
Age: 63
Thomas G. Wellner President, Chief Executive Officer
Tom S. Weber Chief Financial Officer, Executive Vice President
Peter Van der Velden MBA Director
Gerald J. Barry Independent Trustee
Age: 59
Steven W. Chepa Independent Trustee
Age: 73
Joseph Fairbrother Independent Trustee
Age: 56
Robert P. Fisher Jr. Independent Trustee
Age: 57